Growth Metrics

Cryoport (CYRX) Common Equity (2016 - 2026)

Cryoport has reported Common Equity over the past 16 years, most recently at $495.0 million for Q1 2026.

  • Quarterly Common Equity rose 24.12% to $495.0 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $495.0 million through Mar 2026, up 24.12% year-over-year, with the annual reading at $502.6 million for FY2025, 25.07% up from the prior year.
  • Common Equity was $495.0 million for Q1 2026 at Cryoport, down from $502.6 million in the prior quarter.
  • Over five years, Common Equity peaked at $609.4 million in Q1 2022 and troughed at $398.8 million in Q1 2025.
  • The 5-year median for Common Equity is $513.3 million (2025), against an average of $502.5 million.
  • Year-over-year, Common Equity fell 26.49% in 2024 and then grew 29.74% in 2025.
  • A 5-year view of Common Equity shows it stood at $555.8 million in 2022, then fell by 12.02% to $489.0 million in 2023, then fell by 17.82% to $401.9 million in 2024, then increased by 25.07% to $502.6 million in 2025, then dropped by 1.52% to $495.0 million in 2026.
  • Per Business Quant, the three most recent readings for CYRX's Common Equity are $495.0 million (Q1 2026), $502.6 million (Q4 2025), and $513.3 million (Q3 2025).